Have you used Real World Evidence to support an orphan drug application? The data scientists at MMS have compiled a case study on a recent project that might interest you. Read here: https://hubs.li/Q02Nll610 to learn: ✔️ How to identify prevalence for a subset of a disease population, especially when relevant literature support in scientific journals is lacking ✔️ Where we found the data to use as part of the solution ✔️ The outcome that enabled MMS to prove that the orphan drug threshold was met Leave a comment and let us know what you think! #datascience #pharma #biotech
MMS
Pharmaceutical Manufacturing
Canton, MI 51,775 followers
The difference is in the data.
About us
MMS Holdings (MMS) is an award-winning, data-focused clinical research organization (CRO) that supports the pharmaceutical and biotech industries with a proven, scientific approach to complex trial data and regulatory submission challenges. Strong industry experience, an 18-year track record, AI technology-enabled services, and a data-driven approach to drug development make MMS a valuable CRO partner. With a global footprint across four continents, MMS maintains an industry-leading customer satisfaction rating. For more information, visit www.mmsholdings.com
- Website
-
https://www.mmsholdings.com
External link for MMS
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Canton, MI
- Type
- Privately Held
- Founded
- 2006
- Specialties
- Clinical Strategy & Execution, Regulatory Affairs and Submissions, Clinical Programming & Biostatistics, Data Management, Clinical Trial Disclosures, Medical Writing, GCP Auditing, clinical research organization, Use of Real World Evidence, Pharmacovigilance & Drug Safety, Quality Control, Quality Assurance, and Data Science
Locations
Employees at MMS
Updates
-
As we celebrate Labor Day, we want to recognize the hard work and dedication of our incredible team across the US. From our headquarters in Canton, Michigan, to our colleagues extending from coast to coast, your commitment and expertise drive our continued success as a leading data-focused CRO. Labor Day is a time to honor the contributions of all colleagues and reflect on the teamwork that brings these important new therapies to market. We appreciate everything you do! Have a restful and enjoyable Labor Day. #LaborDay #Gratitude #OneMMS
-
Since its launch, the Oncology Center of Excellence (OCE) Real-time Oncology Review (RTOR) Pilot Program has been accelerating the review of new oncology treatments. While it offers earlier FDA engagement and shorter development times, challenges include managing frequent IRs with tight turnaround times, impacts on future submissions, and the complexity of coordinating rolling submissions with rapid review cycles. MMS has extensive experience with RTORs and can support: ➡️ FDA Alignment: Develop a feasible RTOR plan with aggressive timelines. ➡️ Optimized Planning: Ensure rapid and compliant submissions. ➡️ Efficient Data Management: Tailored plans for your program. ➡️ Timely IR Responses: Quick and effective IR management. Read more on how to accelerate your oncology submissions here: https://hubs.li/Q02MS47M0 #Oncology #RTOR #FDA #DrugDevelopment
-
We’re excited to announce that MMS will be exhibiting at the world-renowned Society for Clinical Data Management (SCDM) Annual Conference in Boston next month! This year’s conference, aptly titled “The Festival of Opportunity,” is packed with cutting-edge technology, world-class speakers, and key presentations on topics ranging from CDS and analytics to AI and cognitive tech. While you’re there, visit our booth #313 to: ✅ Discover new insights by engaging with our experts and learning about the latest advancements in clinical data management ✅ Explore powerful technology and see how our solutions can drive data integrity and increase patient safety ✅ Network with peers, meet new friends, and connect with industry leaders from around the globe Let’s explore how we can shape the future of pharma together. Register now and message us to set a meeting: https://hubs.li/Q02MH4Vy0 #SCDM24
-
We recently posted a new blog article titled "Validation of Clinical Dashboards for Decision Making!" From our perspective, validation is the key to ensuring that clinical dashboard standards are upheld. By following the 3 steps outlined in this article, we can minimize oversight and prevent misrepresentation within clinical dashboards. Read our insights here: https://hubs.li/Q02MvT1X0 #DataScience #PowerBI #ClinicalData
-
Today marks the beginning of our highly anticipated PHUSE Single Day Event (SDE) in Bloemfontein, South Africa – The Efficiency Journey: Digital Transformation, Automation, and Open Source! SDE Chairs Pieter Cloete and Landró Van der Walt are kicking off today’s event, setting the stage for an exciting day filled with innovation and insights! 📊 Presentations to watch: ✔️ Vangeli Grammatikos and Burger Lubbe: Saying Please to the Machine: The Art of Prompt Engineering ✔️ Duncan Changfoot and Moleboheng Madela: Navigating the Intersection of Leadership: How Digital Transformation Altered My Perspective 💬 Join the panel discussion led by Eric Harvey and Faheeza Rangunwala on "The Efficiency Journey" to dive deeper into topics on digital transformation, automation, and open-source trends. Don’t miss out—ask your questions or connect with our experts! 🔗 Explore the full agenda here and message us if you’d like a copy of the slides: https://lnkd.in/gAgq8jZu #PHUSE #DigitalTransformation #Automation #OpenSource #PromptEngineering #Biometrics #OneMMS #DataScience #SouthAfrica
-
MMS is thrilled to share this outstanding feedback from the Head of Biometrics at an EU-based pharmaceutical company! It’s not often that people say you’re “one of the best,” and such recognition speaks volumes about the dedication, expertise, and professionalism of our team. This type of feedback is better than any industry award, because it comes from the heart. ❤️ Faced with an urgent delivery and little margin for error, the comprehensive biometrics experts at MMS took on the challenge with precision and excellence. If you need biometrics support, connect with us here: https://hubs.li/Q02M00qm0 #SponsorsSay #Biometrics #OneMMS
-
During Session 8 of DIA's upcoming Global Clinical Trial Disclosure and Data Transparency Conference, our very own Raina Agarwal will be presenting on “Accelerating Clinical Trials Publication by Proactively Protecting CCI: Adapting to EU-CTIS Revised Transparency Rules!” Raina, Associate Director of Clinical Trial Disclosure and Transparency, will be joined by session chair Scott Feiner, Senior Manager of Trial Disclosure at AbbVie, and fellow thought leader Dr. Marianne Lunzer, Assessor in the Department of Clinical Trials, Federal Office for Safety in Health Care at AGES - Österreichische Agentur für Gesundheit und Ernährungssicherheit, Austria. Learn about the latest requirements in clinical trial disclosure and data transparency, and engage in in-depth discussions at the event. Register and join us: https://hubs.li/Q02LSw9p0 #CCI #CTIS #ClinicalTrialTransparency
-
At a recent event in Amsterdam, our full-spectrum biometrics solutions team observed that Bayesian methodology in efficacy analyses is quickly emerging in the pharmaceutical industry. A presentation by a member of the EMA methods working group highlighted key perspectives on using Bayesian methods for sensitivity and confirmatory purposes. However, utilizing Bayesian methodology for Primary Endpoints may present challenges if frequentist alternatives exist. Early communication with the EMA is crucial to ensure the methodology is 'fit-for-purpose.' At MMS, our biostatisticians leverage in-house expertise to guide Sponsors through Bayesian assessments while exploring other effective alternatives. Read more perspectives from the event here: https://hubs.li/Q02LH6Nj0 #ClinicalResearch #BayesianMethodology #EMA #Biostatistics #Biometrics #OneMMS
-
We’re just 1 week away from our highly anticipated PHUSE Single Day Event (SDE) in Bloemfontein, titled "The Efficiency Journey: Digital Transformation, Automation, and Open Source!" This is your chance to dive into the latest advancements, engage with biometrics experts and professionals, and gain the following: ➡️ Insights into digital transformation and its impact ➡️ Strategies for effective automation ➡️ The benefits and challenges of open source Come connect, learn, and share experiences with your peers. We look forward to hosting you! Secure your spot now: https://hubs.li/Q02KY0y20 #PHUSE #Biometrics #Bloemfontein